Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges

What is it about?

Sarcopenic obesity is a condition in older adults characterized by reduced muscle mass and function along with obesity. Traditional treatments include exercise and diet, but newer medications like GLP-1RAs and GIP/GLP-1RAs show promise though they carry risks. The review suggests cautious use of these medications must come with an emphasis on healthful diet and exercise, targeting of obesity-related conditions, close monitoring, and quick discontinuation in case of adverse events.

Featured Image